bms: I honestly don't know what to do with the news about the MS and Georgetown acquisitions!!! The value of the Diagnostic Company in 2 years is incalculable....especially if the complete suite of blood tests enables us to replace the need for Amyvid all together! I really don't know how to calculate what the market cap could be in 2 or 3 years based on potential revenues? 3 Billion, 4 Billion? For the Diagnostic Company alone? Unbelievable.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links